A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.
about
Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany.Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
P2860
A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A model of long-term metabolic ...... aluating treatment strategies.
@ast
A model of long-term metabolic ...... aluating treatment strategies.
@en
type
label
A model of long-term metabolic ...... aluating treatment strategies.
@ast
A model of long-term metabolic ...... aluating treatment strategies.
@en
prefLabel
A model of long-term metabolic ...... aluating treatment strategies.
@ast
A model of long-term metabolic ...... aluating treatment strategies.
@en
P2093
P2860
P1433
P1476
A model of long-term metabolic ...... aluating treatment strategies.
@en
P2093
Adrian Bagust
Andrew S Perry
Marc Evans
Murray Stewart
Philip D Home
Sophie Beale
P2860
P356
10.2165/00019053-200624001-00002
P478
24 Suppl 1
P577
2006-01-01T00:00:00Z
P6179
1052794248